424 Capital exits health engagement firm Reverba in strategic sale

The Seattle-based company helps pharmaceutical and biotech companies engage with patients and healthcare professionals across the therapy lifecycle.

2 minutes ago•2 mins read
LinkedInXEmail
LinkedInXEmail